|
Characteristics
|
Delayed converters
|
Converters
|
Crude odd ratio (95% confidence interval)
|
p value
|
|---|
|
(n = 94)
|
n (%)
|
(n = 1192)
|
n (%)
|
|---|
|
Age 33 years old
|
55 (58.5)
|
582 (48.8)
|
1.5 (0.9- 2.3)
|
0.04
|
|
Male sex
|
62 (66.0)
|
710 (59.6)
|
1.3 (0.8- 2.0)
|
0.22
|
|
Years
|
|
2006
|
7 (7.4)
|
208 (17.5)
|
Reference
|
-
|
|
2007
|
1 (1.1)
|
147 (12.3)
|
0.2 (0.02- 1.7)
|
0.14
|
|
2008
|
6 (6.4)
|
180 (15.1)
|
0.9 (0.3- 3.0)
|
0.9
|
|
2009
|
26 (27.7)
|
178 (14.9)
|
4.3 (1.8- 10.2)
|
<0.01
|
|
2010
|
15 (16.0)
|
153 (12.8)
|
2.9 (1.2- 7.3)
|
<0.01
|
|
2011
|
20 (21.3)
|
211 (17.7)
|
2.8 (1.2- 6.8)
|
0.02
|
|
2012
|
19 (20.2)
|
114 (9.6)
|
4.9 (2.0- 12.1)
|
<0.01
|
|
Positive HIV status
|
20 (23.5)
|
218 (22.0)
|
1.1(0.6- 1.8)
|
0.74
|
|
ART* treatment
|
7 (38.9)
|
74 (42.3)
|
0.9 (0.3- 2.3)
|
0.78
|
|
Previous tuberculosis treatment history
|
8 (8.8)
|
97 (8.4)
|
1.1 (0.5- 2.2)
|
0.50
|
|
Initial smear grading
|
|
1+
|
2 (2.1)
|
180 (15.1)
|
Reference
|
-
|
|
2+
|
43 (45.7)
|
546 (45.8)
|
7.1 (1.7- 29.5)
|
<0.01
|
|
3+
|
49 (52.1)
|
466 (39.1)
|
9.5 (2.3- 39.3)
|
<0.01
|
- *Antiretroviral treatment.
